Mortality and cancer incidence in 263 patients with ataxia-telangiectasia - PubMed (original) (raw)
- PMID: 3459930
Comparative Study
Mortality and cancer incidence in 263 patients with ataxia-telangiectasia
D Morrell et al. J Natl Cancer Inst. 1986 Jul.
Abstract
Mortality and cancer incidence were measured retrospectively in 263 ataxia-telangiectasia (A-T) homozygotes. For white and black A-T patients, respectively, all-cause mortality was 50 and 147 times higher than expected based on U.S. mortality rates. There were 52 primary cancers, representing a 61-fold cancer excess for white probands and a 184-fold excess for black probands. The cancer excess was most pronounced for lymphoma, with 252- and 750-fold excesses observed for whites and blacks, respectively. All the age-specific mortality and cancer incidence rates for blacks exceeded those for whites, and overall mortality was 3.0 times higher for black probands than for whites (P less than .001), whereas cancer incidence was 2.2 times higher (P less than .06). Among the white A-T patients, 36% of those who had died had lived at least until 20 years of age, and 33% of those still living were at least 20 years old.
Similar articles
- Breast and other cancers in families with ataxia-telangiectasia.
Swift M, Reitnauer PJ, Morrell D, Chase CL. Swift M, et al. N Engl J Med. 1987 May 21;316(21):1289-94. doi: 10.1056/NEJM198705213162101. N Engl J Med. 1987. PMID: 3574400 - Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain.
Pippard EC, Hall AJ, Barker DJ, Bridges BA. Pippard EC, et al. Cancer Res. 1988 May 15;48(10):2929-32. Cancer Res. 1988. PMID: 3359449 - Incidence of cancer in 161 families affected by ataxia-telangiectasia.
Swift M, Morrell D, Massey RB, Chase CL. Swift M, et al. N Engl J Med. 1991 Dec 26;325(26):1831-6. doi: 10.1056/NEJM199112263252602. N Engl J Med. 1991. PMID: 1961222 - [Clinical, biological and genetic study of 24 patients with ataxia telangiectasia from southern Tunisia].
Triki C, Feki I, Meziou M, Turki H, Zahaf A, Mhiri C. Triki C, et al. Rev Neurol (Paris). 2000 Jul;156(6-7):634-7. Rev Neurol (Paris). 2000. PMID: 10891797 Review. French. - Cancer predisposition of ataxia-telangiectasia heterozygotes.
Swift M, Chase CL, Morrell D. Swift M, et al. Cancer Genet Cytogenet. 1990 May;46(1):21-7. doi: 10.1016/0165-4608(90)90004-t. Cancer Genet Cytogenet. 1990. PMID: 2184933 Review.
Cited by
- Cancers Related to Immunodeficiencies: Update and Perspectives.
Mortaz E, Tabarsi P, Mansouri D, Khosravi A, Garssen J, Velayati A, Adcock IM. Mortaz E, et al. Front Immunol. 2016 Sep 20;7:365. doi: 10.3389/fimmu.2016.00365. eCollection 2016. Front Immunol. 2016. PMID: 27703456 Free PMC article. Review. - The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions.
Yuan Z, Villagra A, Peng L, Coppola D, Glozak M, Sotomayor EM, Chen J, Lane WS, Seto E. Yuan Z, et al. Mol Cell Biol. 2010 Jun;30(12):3004-15. doi: 10.1128/MCB.01023-09. Epub 2010 Apr 5. Mol Cell Biol. 2010. PMID: 20368352 Free PMC article. - Insulin resistance and atherosclerosis.
Razani B, Chakravarthy MV, Semenkovich CF. Razani B, et al. Endocrinol Metab Clin North Am. 2008 Sep;37(3):603-21, viii. doi: 10.1016/j.ecl.2008.05.001. Endocrinol Metab Clin North Am. 2008. PMID: 18775354 Free PMC article. Review. - Mechanisms involved in Burkitt's tumor formation.
Campanero MR. Campanero MR. Clin Transl Oncol. 2008 May;10(5):250-5. doi: 10.1007/s12094-008-0193-x. Clin Transl Oncol. 2008. PMID: 18490240 Review. - Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review.
Jerzak KJ, Mancuso T, Eisen A. Jerzak KJ, et al. Curr Oncol. 2018 Apr;25(2):e176-e180. doi: 10.3747/co.25.3707. Epub 2018 Apr 30. Curr Oncol. 2018. PMID: 29719442 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical